Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 5, 2024

An aging-sensitive compensatory secretory phospholipase that confers neuroprotection and cognitive resilience

 Sounds like your doctor should completely understand this so your cognitive resilience can be built up again to prevent dementia. At least if you have a competent doctor! Do you have a competent? doctor?

An aging-sensitive compensatory secretory phospholipase that confers neuroprotection and cognitive resilience

Amar Sahay1

ORCID

Email

Cinzia Vicidomini2

Travis Goode3

ORCID

Kathleen McAvoy1

Ruilin Yu4

ORCID

Conor Beveridge4

Sanjay Iyer4

Matheus Victor5

Noelle Leary5

Michael Steinbaugh3

ORCID

Zon Lai6

Marina Lyon7

Manuel Silvestre7

Gracia Bonilla7

Ruslan Sadreyev8

Tobias Walther9

Shannan Sui10

Takaomi Saido11

ORCID

Kei Yamamoto12

Makoto Murakami13

Li-Huei Tsai5

ORCID

Gaurav Chopra14

ORCID

Liam Evans7

Massachusetts General Hospital & Harvard Medical School,

CNR Neuroscience Insitute,

Harvard University,

Purdue University,

Massachusetts Institute of Technology,

Harvard Chan Advanced Multi-omics Platform, Harvard T.H. Chan School of Public Health,

MGH and HMS,

Massachusetts General Hospital/ Harvard Medical School,

MSKCC,

10 Harvard Chan Bioinformatics Core, Harvard School of Public Health,

11 RIKEN Center for Brain Science,

12 Tokushima University,

13 Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science,

14 Purdue University West Lafayette

A preprint is a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.

Content submitted to Research Square is screened by our in-house editorial staff. For more information about our screening process, see our Editorial Policies.

 

https://doi.org/10.21203/rs.3.rs-4920738/v1

This work is licensed under a CC BY 4.0 License

Breakdown of lipid homeostasis is thought to contribute to pathological aging, the largest risk factor for neurodegenerative disorders such as Alzheimer’s Disease (AD). Cognitive reserve theory posits a role for compensatory mechanisms in the aging brain in preserving neuronal circuit functions, staving off cognitive decline, and mitigating risk for AD. However, the identities of such mechanisms have remained elusive. A screen for hippocampal dentate granule cell (DGC) synapse loss-induced factors identified a secreted phospholipase, Pla2g2f, whose expression increases in DGCs during aging. Pla2g2f deletion in DGCs exacerbates aging-associated pathophysiological changes including synapse loss, inflammatory microglia, reactive astrogliosis, impaired neurogenesis, lipid dysregulation and hippocampal-dependent memory loss. Conversely, boosting Pla2g2f in DGCs during aging is sufficient to preserve synapses, reduce inflammatory microglia and reactive gliosis, prevent hippocampal-dependent memory impairment and modify trajectory of cognitive decline. Ex vivo, neuronal-PLA2G2F mediates intercellular signaling to decrease lipid droplet burden in microglia. Boosting Pla2g2f expression in DGCs of an aging-sensitive AD model reduces amyloid load and improves memory. Our findings implicate PLA2G2F as a compensatory neuroprotective factor that maintains lipid homeostasis to counteract aging-associated cognitive decline.

No comments:

Post a Comment